ArticleJournal of medical Internet research2025
Forecasting Subjective Cognitive Decline: AI Approach Using Dynamic Bayesian Networks.
Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bayesian networks to estimate prognosis in vascular cognitive impairment and small vessel disease: Integrated analyses of interdependent contributors to multiple outcomes.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026Article
- From fragmented neurotechnologies to closed-loop brain health systems: integrating artificial intelligence, digital health, digital twins, and advanced materials for brain disorders.Frontiers in bioengineering and biotechnology · 2026Article
- Intelligent Prediction Platform for Sepsis Risk Based on Real-Time Dynamic Temporal Features: Design Study.JMIR medical informatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSeveral potentially modifiable risk factors are associated with subjective cognitive decline (SCD). However, developmental patterns of these risk factors have not been used before to forecast later SCD. Practical tools for the prevention of cognitive decline are needed.
objectiveWe examined multifactorial trajectories of risk factors and their associations with SCD using an artificial intelligence (AI) approach to build a score calculator that forecasts later SCD. In addition, we aimed to develop a new risk score tool to facilitate personalized risk assessment and intervention planning and to validate SCD against register-based dementia diagnoses and dementia-related medications.
methodsFive repeated surveys (2000-2022) of the Helsinki Health Study (N=8960; n=7168, 80% women, aged 40-60 years in phase 1) were used to build dynamic Bayesian networks for estimating the odds of SCD. The model structure was developed using expert knowledge and automated techniques, implementing a score-based approach for training dynamic Bayesian networks with the quotient normalized maximum likelihood criterion. The developed model was used to predict SCD (memory, learning, and concentration) based on the history of consumption of fruit and vegetables, smoking, alcohol consumption, leisure time physical activity, BMI, and insomnia symptoms, adjusting for sociodemographic covariates. Model performance was assessed using 5-fold cross-validation to calculate the area under the receiver operating characteristic curve. Bayesian credible intervals were used to quantify uncertainty in model estimates.
resultsOf the participants, 1842 of 5865 (31%) reported a decline in memory, 2818 of 5879 (47.4%) in learning abilities, and 1828 of 5888 (30.7%) in concentration in 2022. Physical activity was the strongest predictor of SCD in a 5-year interval, with an odds ratio of 0.76 (95% Bayesian credible interval 0.59-0.99) for physically active compared to inactive participants. Alcohol consumption showed a U-shaped relationship with SCD. Other risk factors had minor effects. Moreover, our validation confirmed that SCD has prognostic value for diagnosed dementia, with individuals reporting memory decline being over 3 times more likely to have dementia in 2017 (age 57-77 years), and this risk increased to more than 5 times by 2022 (age 62-82 years). The receiver operating characteristic curve analysis further supported the predictive validity of our outcome, with an area under the curve of 0.78 in 2017 and 0.75 in 2022.
conclusionsA new risk score tool was developed that enables individuals to inspect their risk profiles and explore potential targets for interventions and their estimated contributions to later SCD. Using AI-driven predictive modeling, the tool can aid health care professionals in providing personalized prevention strategies. A dynamic decision heatmap was presented as a communication tool to be used at health care consultations. Our findings suggest that early identification of individuals with SCD could improve targeted intervention strategies for reducing dementia risk. Future research should explore the integration of AI-based risk prediction models into clinical workflows and assess their effectiveness in guiding lifestyle interventions to mitigate SCD and dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.